144 Participants Needed

Robotic Gait Training for Spinal Cord Injury

(DOOR SCI Trial)

AR
CO
FM
Overseen ByFaith Meza, MPH
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Baylor Research Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 4 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

This trial uses robotic devices and magnetic stimulation to help people with partial spinal cord injuries recover better. It focuses on rehabilitation to maximize recovery by practicing walking and stimulating the brain. Robotic devices and magnetic stimulation are increasingly used in neurorehabilitation to facilitate repetitive motor training and enhance recovery in individuals with spinal cord injuries.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Robotic Gait Training for Spinal Cord Injury?

Research shows that robotic-assisted gait training (RAGT) can significantly improve walking distance, leg strength, and mobility in people with spinal cord injuries, especially when started soon after the injury. It has been found to be more effective than conventional overground training in enhancing walking ability and independence.12345

Is robotic gait training safe for humans?

Research on robotic gait training, including devices like Lokomat and wearable exoskeletons, suggests it is generally safe for people with spinal cord injuries, although specific safety data is not detailed in the studies.13678

How is Robotic Gait Training different from other treatments for spinal cord injury?

Robotic Gait Training (RAGT) is unique because it uses advanced robotic systems to assist with walking, providing precise and consistent movement patterns that can help improve walking abilities in people with spinal cord injuries. Unlike traditional therapies, RAGT can be delivered through stationary systems like Lokomat or wearable exoskeletons, offering flexibility in rehabilitation settings.13467

Research Team

CS

Chad Swank, PhD, PT, NCS

Principal Investigator

Baylor Research Institute

Eligibility Criteria

This trial is for individuals with motor incomplete spinal cord injuries, in the acute or subacute recovery phase. Participants must be medically stable and receiving care at Baylor Scott & White Institute for Rehabilitation. They should fit within the Ekso robotic exoskeleton's size limits and manage bladder/bowel continence. Exclusions include severe TBI, degenerative conditions, cognitive impairments, pregnancy, or living over 90 miles from the institute.

Inclusion Criteria

I have an incomplete spinal cord injury that affects my movement.
You must fit within the size limits of the Ekso robotic exoskeleton.
I am receiving care at Baylor Scott & White Institute for Rehabilitation.
See 4 more

Exclusion Criteria

I have a condition that is getting progressively worse.
I have a moderate to severe brain injury.
You have a developmental disability, significant mental health diagnosis, or other thinking problems before the start of the study.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Inpatient Rehabilitation

Participants begin robotic gait training (RGT) during inpatient rehabilitation

6-12 weeks
Multiple sessions per week

Outpatient Rehabilitation

Continuation of RGT sessions in outpatient settings with varying frequency

6-12 weeks
2-4 sessions per week

Follow-up

Participants are monitored for safety and effectiveness after treatment

9 months
Periodic assessments at 1-month and 9-months post-SCI

Treatment Details

Interventions

  • Robotic Gait Training
  • Usual Care (UC) Gait Training
Trial OverviewThe DOOR SCI study is testing how different amounts of robotic gait training (RGT) combined with transcranial magnetic stimulation (TMS) affect functional outcomes and brain changes after a spinal cord injury. This happens during inpatient rehab and continues into early outpatient care.
Participant Groups
4Treatment groups
Experimental Treatment
Active Control
Group I: Moderate FrequencyExperimental Treatment1 Intervention
Subjects will receive 3 sessions of robotic gait training (RGT) per week for 8 weeks
Group II: Low FrequencyExperimental Treatment1 Intervention
Subjects will receive 2 sessions of robotic gait training (RGT) per week for 12 weeks
Group III: High FrequencyExperimental Treatment1 Intervention
Subjects will receive 4 sessions of robotic gait training (RGT) per week for 6 weeks
Group IV: Control GroupActive Control1 Intervention
Subjects will receive usual care gait training without robotic gait training

Robotic Gait Training is already approved in European Union, United States, Canada, Switzerland for the following indications:

🇪🇺
Approved in European Union as Robotic Assisted Gait Training for:
  • Spinal cord injury
  • Cerebral palsy
  • Stroke
  • Multiple sclerosis
  • Parkinson’s disease
🇺🇸
Approved in United States as Robotic Assisted Gait Training for:
  • Spinal cord injury
  • Cerebral palsy
  • Stroke
  • Multiple sclerosis
  • Parkinson’s disease
🇨🇦
Approved in Canada as Robotic Assisted Gait Training for:
  • Spinal cord injury
  • Cerebral palsy
  • Stroke
  • Multiple sclerosis
  • Parkinson’s disease
🇨🇭
Approved in Switzerland as Robotic Assisted Gait Training for:
  • Spinal cord injury
  • Cerebral palsy
  • Stroke
  • Multiple sclerosis
  • Parkinson’s disease

Find a Clinic Near You

Who Is Running the Clinical Trial?

Baylor Research Institute

Lead Sponsor

Trials
210
Recruited
205,000+

Texas Woman's University

Collaborator

Trials
90
Recruited
5,900+

United States Department of Defense

Collaborator

Trials
940
Recruited
339,000+

Texas Woman's University

Collaborator

Trials
1
Recruited
140+

Findings from Research

The Walkbot robotic-assisted gait training (RAGT) system significantly improved hip and knee movement and reduced stiffness in individuals with paraplegia or quadriplegia after 8 weeks of training, involving an average of 43 sessions.
This study provides the first clinical evidence that Walkbot RAGT can enhance functional mobility and daily activities in patients who had previously plateaued in their recovery, indicating its potential as a valuable rehabilitation tool.
Effects of Walkbot gait training on kinematics, kinetics, and clinical gait function in paraplegia and quadriplegia.Hwang, J., Shin, Y., Park, JH., et al.[2019]
Robot-assisted gait training (RAGT) significantly improves walking-related outcomes, such as gait distance and leg strength, in patients with incomplete spinal cord injury, especially during the acute phase of recovery, compared to over-ground training (OGT).
In chronic spinal cord injury patients, RAGT also enhances walking speed and balance more effectively than no intervention, suggesting it is a valuable rehabilitation technique for restoring mobility and promoting a healthier lifestyle.
Robot-assisted gait training (Lokomat) improves walking function and activity in people with spinal cord injury: a systematic review.Nam, KY., Kim, HJ., Kwon, BS., et al.[2020]
A network meta-analysis of 12 studies involving 353 participants with spinal cord injury found that wearable exoskeleton-assisted walking (EAW) significantly improved walking distance and speed compared to Lokomat training.
While both Lokomat and EAW enhanced locomotor abilities, EAW showed a higher probability of improving walking speed, suggesting it may be a more effective option for enhancing locomotion in individuals with spinal cord injury.
Comparison of Efficacy of Lokomat and Wearable Exoskeleton-Assisted Gait Training in People With Spinal Cord Injury: A Systematic Review and Network Meta-Analysis.Zhang, L., Lin, F., Sun, L., et al.[2022]

References

Effects of Walkbot gait training on kinematics, kinetics, and clinical gait function in paraplegia and quadriplegia. [2019]
Robot-assisted gait training (Lokomat) improves walking function and activity in people with spinal cord injury: a systematic review. [2020]
Comparison of Efficacy of Lokomat and Wearable Exoskeleton-Assisted Gait Training in People With Spinal Cord Injury: A Systematic Review and Network Meta-Analysis. [2022]
Energy cost and psychological impact of robotic-assisted gait training in people with spinal cord injury: effect of two different types of devices. [2021]
Effectiveness of robot-assisted gait training in persons with spinal cord injury: a systematic review. [2022]
Gait training using a wearable robotic hip device for incomplete spinal cord injury: A preliminary study. [2023]
The effects of robot assisted gait training on temporal-spatial characteristics of people with spinal cord injuries: A systematic review. [2019]
Effects of end-effector robot-assisted gait training on gait ability, muscle strength, and balance in patients with spinal cord injury. [2023]